Financials EMEIS

Equities

EMEIS

FR001400NLM4

Healthcare Facilities & Services

Real-time Euronext Paris 15:22:23 05/07/2024 BST 5-day change 1st Jan Change
12.91 EUR +0.39% Intraday chart for EMEIS +12.42% -23.60%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 7,380 6,946 5,691 398.9 2,195 1,670 - -
Enterprise Value (EV) 1 14,710 15,239 16,866 12,926 10,711 9,180 7,879 6,461
P/E ratio 32.7 x 44.1 x 87.2 x -0.1 x 0.13 x -0.01 x -0.01 x 0.01 x
Yield 1.14% 0.84% - - - - - 6,609%
Capitalization / Revenue 1.97 x 1.77 x 1.33 x 0.09 x 0.42 x 0.31 x 0.28 x 0.26 x
EV / Revenue 3.93 x 3.89 x 3.94 x 2.76 x 2.06 x 1.68 x 1.31 x 1.02 x
EV / EBITDA 15.5 x 16.4 x 16.3 x 17.1 x 16.4 x 10.6 x 8.4 x 6.49 x
EV / FCF -70 x -72.2 x 32.6 x 51.5 x 49.4 x 22.5 x 9.72 x 5.48 x
FCF Yield -1.43% -1.38% 3.07% 1.94% 2.03% 4.44% 10.3% 18.3%
Price to Book 2.45 x 1.99 x 1.5 x -0.27 x - 0 x 0 x 0 x
Nbr of stocks (in thousands) 64.6 64.6 64.6 64.6 129,867 129,867 - -
Reference price 2 114,300 107,550 88,100 6,172 16.90 12.86 12.86 12.86
Announcement Date 17/03/20 16/03/21 11/03/22 12/05/23 07/05/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 3,740 3,922 4,285 4,681 5,198 5,452 5,994 6,349
EBITDA 1 949.4 926.5 1,037 756 651.5 866.9 938.1 995.3
EBIT 1 503.7 422.9 395.7 -49 -16 -6.8 100.9 -
Operating Margin 13.47% 10.78% 9.24% -1.05% -0.31% -0.12% 1.68% -
Earnings before Tax (EBT) 1 325.7 210.3 105.8 -4,591 1,400 -30 - -
Net income 1 233.8 160 65.18 -4,027 1,355 -291.6 -175.2 136
Net margin 6.25% 4.08% 1.52% -86.03% 26.07% -5.35% -2.92% 2.14%
EPS 2 3,492 2,440 1,010 -62,330 130.0 -1,670 -900.0 860.0
Free Cash Flow 1 -210 -211 517 251 216.9 407.5 810.4 1,180
FCF margin -5.61% -5.38% 12.06% 5.36% 4.17% 7.47% 13.52% 18.58%
FCF Conversion (EBITDA) - - 49.85% 33.2% 33.29% 47.01% 86.38% 118.54%
FCF Conversion (Net income) - - 793.1% - 16.01% - - 867.5%
Dividend per Share 2 1,300 900.0 - - - - - 850.0
Announcement Date 17/03/20 16/03/21 11/03/22 12/05/23 07/05/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2020 S1 2020 S2 2021 S1 2021 Q3 2022 Q1 2022 Q2 2022 S1 2022 Q3 2023 Q1 2023 Q2
Net sales 1 1,904 2,018 2,069 1,110 1,148 1,192 2,312 1,181 1,234 1,305
EBITDA - - - - - - - - - -
EBIT - - - - - - - - - -
Operating Margin - - - - - - - - - -
Earnings before Tax (EBT) - - - - - - - - - -
Net income - - - - - - - - - -
Net margin - - - - - - - - - -
EPS - - - - - - - - - -
Dividend per Share - - - - - - - - - -
Announcement Date 21/07/20 16/03/21 20/07/21 03/11/21 05/05/22 20/07/22 20/07/22 08/11/22 07/08/23 07/11/23
1EUR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 7,330 8,293 11,175 12,527 8,516 7,510 6,209 4,791
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 7.721 x 8.951 x 10.78 x 16.57 x 13.07 x 8.663 x 6.619 x 4.814 x
Free Cash Flow 1 -210 -211 517 251 217 408 810 1,180
ROE (net income / shareholders' equity) 7.8% 5.01% 1.79% - - -11.4% -7.3% -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 46,678 54,090 58,825 -23,236 - 15,015 14,620 15,060
Cash Flow per Share 2 6,586 11,382 11,679 6,342 35.00 309,320 - -
Capex 1 651 915 1,271 159 149 198 210 -
Capex / Sales 17.41% 23.33% 29.66% 3.39% 2.87% 3.64% 3.51% -
Announcement Date 17/03/20 16/03/21 11/03/22 12/05/23 07/05/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
4
Last Close Price
12.86 EUR
Average target price
11,725 EUR
Spread / Average Target
+91,060.01%
Consensus

Quarterly revenue - Rate of surprise